Announcements Trials
Browse Landscape

Phase

Phase NA 12Phase 3 4Phase 2 3Phase 4 2Phase 1/2 1

Status

Unknown 2Recruiting 2Completed 2Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 33Neoplasms 16Prostatic Neoplasms 15Lung Neoplasms 11Carcinoma, Hepatocellular 11Multiple Myeloma 9Colorectal Neoplasms 9Carcinoma, Non-Small-Cell Lung 9Precursor Cell Lymphoblastic Leukemia-Lymphoma 6Papillomavirus Infections 6Pain, Postoperative 6Neoplasm Metastasis 6Liver Neoplasms 6Leukemia, Myeloid, Acute 6Stomach Neoplasms 5Recurrence 5Lymphoma, Non-Hodgkin 4Kidney Neoplasms 4Heart Failure 4Glioma 4Febrile Neutropenia 4Carcinoma, Renal Cell 4Brain Neoplasms 4Warts 3Vomiting 3Uterine Cervical Neoplasms 3Urinary Bladder Neoplasms 3Skin Neoplasms 3Rectal Neoplasms 3Pituitary Neoplasms 3

Interventions

sacubitril and valsartan sodium hydrate drug combination 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Recruiting × Cardiotoxicity × Clear all
NCT06183437 2026-03-30

STOP-MED CTRCD

University Health Network, Toronto

Phase 4 Recruiting
335 enrolled

Heart Failure, Neoplasms, Cardiotoxicity

NCT05465031 2025-03-14

Sacubitril/Valsartan in PriMAry preventIoN of the Cardiotoxicity of Systematic breaST canceR trEAtMent (MAINSTREAM)

Silesian Centre for Heart Diseases

Phase 4 Recruiting
600 enrolled
Breast

Breast Diseases, Breast Neoplasms, Heart Failure, Neoplasms, Second Primary, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡